Biodexa Pharmaceuticals BDRX Growth Metrics (2014-2026)

NASDAQ BDRX
$0.66 +0.01 (+1.71%)
At close: Sep 30, 2026 · 4:00 PM EDT
Reported Financials

Biodexa Pharmaceuticals Quarterly Growth Metrics

Periods 12 quarters
Latest Jun 2026

Biodexa Pharmaceuticals growth metrics data for the quarter ended Jun 2026. These growth metrics cover 12 quarters of results from Dec 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2024 Dec2025 Jun2026
Growth Ratios
EBIT Margin Growth (1y) -5176.0016,302.00-18426.00
EBIT Margin Growth (3y) -7300.00
EBT Margin Growth (1y) -6509.0017,307.00-19933.00
EBT Margin Growth (3y) -9135.00
FCF Margin Growth (1y) 19,598.00-203.00-18089.00
FCF Margin Growth (3y) 1,306.00
Gross Margin Growth (1y) -6539.004,445.00-20902.00
Gross Margin Growth (3y) -22996.00
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y) -414.88%-75.99%73.49%-191.38%75.39%-479.70%54.19%65.48%-128.26%
Interest Coverage Ratio Growth (3y)Interest Cover Growth (3y) -33.92%-10.78%42.50%-60.79%13.22%-10.50%42.61%29.39%
Interest Coverage Ratio Growth (5y)Interest Cover Growth (5y) -11.49%-14.16%12.78%-13.99%5.88%11.06%
Net Margin Growth (1y) -4682.0013,815.00-26708.00
Net Margin Growth (3y) -17575.00
Operating Margin Growth (1y) -5176.0016,302.00-18426.00
Operating Margin Growth (3y) -7300.00
Return on Assets [ROA] Growth (1y)ROA Growth (1y) -1705.00-7991.003,291.00-33706.001,063.00-10238.002,361.001,252.00
Return on Assets [ROA] Growth (3y)ROA Growth (3y) -6405.00-38406.00-29352.00-42881.0036,059.0048,658.0047,194.00
Return on Assets [ROA] Growth (5y)ROA Growth (5y) -39049.00-47581.003,416.0039,483.00
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) -2743.00-6328.005,115.00-51666.0023,003.00-109.00
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y) -3956.00-52879.00-76082.0075,397.0089,107.00
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y) -77294.00-23689.0050,981.00
Return on Equity [ROE] Growth (1y)ROE Growth (1y) -2325.00-11998.005,515.00-73334.0022,060.00-10845.006,208.002,079.00
Return on Equity [ROE] Growth (3y)ROE Growth (3y) -8808.00-79817.00-45759.00-62119.0051,863.0068,916.0076,091.00
Return on Equity [ROE] Growth (5y)ROE Growth (5y) -60082.00-68602.00589.0080,131.00
Return on Sales [ROS] Growth (1y)ROS Growth (1y) -5176.0016,302.00-18426.00
Return on Sales [ROS] Growth (3y)ROS Growth (3y) -7300.00

Biodexa Pharmaceuticals Growth Metrics API

Pull Biodexa Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BDRX&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY